Press "Enter" to skip to content

Zika Virus Vaccines Market Predicted to Witness Surge in the Near Future2018 – 2028

Zika Virus Vaccines Market Scope of the Report:

The worldwide market for Zika Virus Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2025, from xx million US$ in 2019, according to a new study.

This report focuses on the Zika Virus Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Request Sample Report @

Zika Virus Vaccines Market Segment by Manufacturers, this report covers

Drivers and Restraints 

The growing prevalence of active Zika virus infection is the foremost factor augmenting the global Zika virus vaccine market. The increasing incidence of Zika fever is fuelling the development of potent vaccines. Moreover, the rising awareness regarding the virus is stimulating the adoption of these vaccines. 

Furthermore, Zika virus infection can be transmitted from an infected mother to her fetus. In such a case, infants are born with microcephaly and other related birth defects. The Brazilian authorities state that since 2014, more than 1,638 babies in the country are born with microcephaly. Thus, the alarming rise of infection is creating a soaring need for vaccines for the prevention and treatment of Zika-linked birth defects. However, in November 2016, the World Health Organization (WHO) announced that Zika virus infection is no longer an epidemic and is anticipated to be less prevalent in the near future, which in turn is limiting the global Zika virus vaccines market in realizing its utmost potential. 

Global Zika Virus Vaccines Market: Region-wise Outlook 

Based on geography, the segments methodically examined in the report are Asia Pacific, North America, Europe, and Rest of the World. The Rest of the World region will be a prominent market throughout the forecast period. The widening base of patients suffering from Zika virus infection is the primary factor driving the demand for their vaccines in the region. At present, Brazil is reported to have the highest number of infected individuals, closely trailed by Columbia and Venezuela. 

Asia Pacific is expected to register a significant CAGR during the same period. The high prevalence of mosquito-borne illness and the improving healthcare infrastructure are promoting the development of Zika virus vaccines. The increasing awareness among populace regarding the infection caused by the virus is also triggering the demand for these vaccines. 

Global Zika Virus Vaccines Market: Competitive Landscape 

The global Zika virus vaccines market is capital intensive nature and is, therefore, dominated by large pharmaceutical firms across the world. Some of the prominent players are Takeda Pharmaceutical Co. Ltd., Immunovaccine Inc., NewLink Genetics Co., Bharat Biotech International Ltd., GeneOne Life Science Inc., Inovio Pharmaceuticals, Inc., Sanofi S.A., GlaxoSmithKline Plc., and Hawaii Biotech Inc. These players are pouring hefty funds into the development of effective and reliable vaccines in order to expand their consumer base and stay relevant in the market.

Request For Discount On This Report @

Reasons to Purchase this Zika Virus Vaccines Market Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis

* Market dynamics scenario, along with growth opportunities of the market in the years to come

* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects

* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.

* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment

* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years

* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

* 1-year analyst support, along with the data support in excel format.

Customize This Report @

The Zika Virus Vaccines Market report has 150 tables and figures browse the report description and TOC:

Table of Contents

1 Study Coverage

1.1 Zika Virus Vaccines Product

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Zika Virus Vaccines Market Size Growth Rate by Type

1.5 Market by Application

1.5.1 Global Zika Virus Vaccines Market Size Growth Rate by Application

2 Executive Summary

2.1 Global Zika Virus Vaccines Market Size

2.1.1 Global Zika Virus Vaccines Revenue 2014-2025

2.1.2 Global Zika Virus Vaccines Production 2014-2025

2.2 Zika Virus Vaccines Growth Rate (CAGR) 2019-2025

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Key Zika Virus Vaccines Manufacturers Zika Virus Vaccines Manufacturing Base Distribution, Headquarters Manufacturers Zika Virus Vaccines Product Offered Date of Manufacturers Enter into Zika Virus Vaccines Market

2.4 Key Trends for Zika Virus Vaccines Markets & Products

3 Market Size by Manufacturers

3.1 Zika Virus Vaccines Production by Manufacturers

3.1.1 Zika Virus Vaccines Production by Manufacturers

3.1.2 Zika Virus Vaccines Production Market Share by Manufacturers

3.2 Zika Virus Vaccines Revenue by Manufacturers

3.2.1 Zika Virus Vaccines Revenue by Manufacturers (2019-2025)

3.2.2 Zika Virus Vaccines Revenue Share by Manufacturers (2019-2025)

3.3 Zika Virus Vaccines Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

More Information…….